https://doi.org/10.1038/s41467-020-17339-6
L
Louise van der Weyden
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
222
Papers
8.1K
Citations
45
h-index
94
i10-index
Louise van der Weyden is an academic researcher from Wellcome Sanger Institute. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Veterinary Oncology Research & Cancer Research and Treatments. The author has an h-index of 45, co-authored 189 publications.
ORCID: 0000-0002-0645-1879Papers by this author
worksTumors induce de novo steroid biosynthesis in T cells to evade immunity
2020 · Nature Communications · 326 citations
The Ras-association domain family (RASSF) members and their role in human tumourigenesis
2007 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 281 citations
https://doi.org/10.1016/j.bbcan.2007.06.003
Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis
2011 · Nature Genetics · 193 citations
https://doi.org/10.1038/ng.990
A high-throughput splinkerette-PCR method for the isolation and sequencing of retroviral insertion sites
2009 · Nature Protocols · 167 citations
https://doi.org/10.1038/nprot.2009.64
<i>Sleeping Beauty</i>screen reveals<i>Pparg</i>activation in metastatic prostate cancer
2016 · Proceedings of the National Academy of Sciences · 119 citations
https://doi.org/10.1073/pnas.1601571113
Sequencing and characterization of the FVB/NJ mouse genome
2012 · Genome biology · 79 citations
https://doi.org/10.1186/gb-2012-13-8-r72
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat